Sat, Nov 1, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index down 0.44% in April, remains up 5.05% YTD

Friday, May 18, 2012
Opalesque Industry Update – Hedge funds lost 0.44% in April 2012, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index remains up 5.05% year-to-date.

“Equity markets in the US, Europe, and Japan traded lower on the month, giving back some of their Q1 profits,” says Sol Waksman, founder and president of BarclayHedge.

“While an economic slowdown in Europe stokes concerns of recession, a growing consensus that quantitative easing in the US is coming to an end confounds investors as to the impact on equity prices.”

In April, 12 of Barclay’s 18 hedge fund indices had losses. The Technology Index was down 1.59%, Pacific Rim Equities lost 1.55%, and Equity Long Bias gave up 0.79%.

On the positive side, the Barclay Equity Short Bias Index jumped 3.61% in April, the Healthcare & Biotechnology Index gained 0.60%, and Fixed Income Arbitrage was up 0.53%.

“Bond prices rose during the month, as evidenced by a 0.68 percent gain in the J.P. Morgan World Government Bond Index. The US 10-year gained more than two percent,” says Waksman.

Equity Short Bias is still the only losing hedge fund strategy in 2012. The Barclay Equity Short Bias Index was down 13.58% at the end of April.

“The steady rise of the S&P 500 has offered very limited trading opportunities for short sellers in 2012,” says Waksman. “But after three straight months of losses, equity short bias traders did manage to catch a bounce in April.”

The Barclay Fund of Funds Index lost 0.33% in April, but remains up 3.07% year-to-date.

Click here to view five years of Barclay Hedge Fund Index data, or download 14 years of monthly data.

(press release)

BarclayHedge was founded in 1985 and actively tracks more than 6,200 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories, 16 CTA categories, and 7 UCITS categories.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Macks aim to raise $750m for real estate debt fund[more]

    From Therealdeal.com: Father-son duo William and Richard Mack and former Blackstone Group managing director Peter Sotoloff are starting a new real estate debt fund. Together, the trio hopes to raise more than $750 million for the private equity fund, according to the Wall Street Journal. The fund wi

  2. Manager Profile - Seth Klarman: Lessons for retail and institutional investors[more]

    From Valuewalk.com: Seth Klarman is virtually unknown outside value circles, despite his impressive record and value of assets under management. On average Baupost has returned 19% p.a. despite holding a large portion of its assets in cash. During the financial crisis, Seth Klarman’s funds lost some

  3. North America - FATCA leads 75% of U.S. expats to consider dropping citizenship[more]

    From International-adviser.com: Nearly three quarters of American expats are considering the renouncement of their citizenship following July’s introduction of the “absurd” Foreign Account Tax Compliance Act (FATCA). The findings, which were revealed in a survey by deVere, come alongside the news th

  4. New app allows asset managers easy interaction with portfolios, securities, holdings, transaction details[more]

    Komfie Manalo, Opalesque Asia: Global financial services software company SS&C Technologies Holdings has launched Explorer, a powerful data visualization and analysis tool that turns critical investment data into meaningful information. Explore

  5. Opalesque Exclusive: Mariner’s new healthcare mandate applies strategic approach across pharmaceutical and biotech sectors[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: A team of two was hired in February this year t